The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
Open accessAbstract
Post-acute sequelae of COVID (PASC), usually referred to as ‘Long COVID’ (a phenotype of COVID-19), is a relatively frequent consequence of SARS-CoV-2 infection, in which symptoms such as breathlessness, fatigue, ‘brain fog’, tissue damage, inflammation, and coagulopathies (dysfunctions of the blood coagulation system) persist long after the initial infection. It bears similarities to other post-viral syndromes, and to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Many regulatory health bodies still do not recognize this syndrome as a separate disease entity, and refer to it under the broad terminology of ‘COVID’, although its demographics are quite different from those of acute COVID-19. A few years ago, we discovered that fibrinogen in blood can clot into an anomalous ‘amyloid’ form of fibrin that (like other β-rich amyloids and prions) is relatively resistant to proteolysis (fibrinolysis). The result, as is strongly manifested in platelet-poor plasma (PPP) of individuals with Long COVID, is extensive fibrin amyloid microclots that can persist, can entrap other proteins, and that may lead to the production of various autoantibodies. These microclots are more-or-less easily measured in PPP with the stain thioflavin T and a simple fluorescence microscope. Although the symptoms of Long COVID are multifarious, we here argue that the ability of these fibrin amyloid microclots (fibrinaloids) to block up capillaries, and thus to limit the passage of red blood cells and hence O2 exchange, can actually underpin the majority of these symptoms. Consistent with this, in a preliminary report, it has been shown that suitable and closely monitored ‘triple’ anticoagulant therapy that leads to the removal of the microclots also removes the other symptoms. Fibrin amyloid microclots represent a novel and potentially important target for both the understanding and treatment of Long COVID and related disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–239 of 239
Bezuidenhout, J. A., Venter, C., Roberts, T. J., Tarr, G. S., Kell, D. B., & Pretorius, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.577523 · Cited by 34
Self-citationNielsen, V. G., & Pretorius, E. (2014) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000160 · Cited by 32
Self-citationBurki, T. K. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00259-5 · Cited by 32
Pretorius, E., Venter, C., Laubscher, G. J., Kotze, M. J., Moremi, K. E., Oladejo, S. O., Watson, L. R., Rajaratnam, K., Watson, B. W., & Kell, D. B. (2021) · Research Square · doi:10.21203/rs.3.rs-1205453/v1 · Cited by 32
Self-citationDisseminated intravascular coagulation
Chang, J. C. (2018) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000727 · Cited by 31
The Uncertainty Surrounding the Burden of Post-acute Consequences of Dengue Infection
Hung, T. M., Wills, B. A., Clapham, H., Yacoub, S., & Turner, H. C. (2019) · Trends in Parasitology · doi:10.1016/j.pt.2019.06.004 · Cited by 31
Molecular foundations of prion strain diversity
Carta, M. C., & Aguzzi, A. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.07.010 · Cited by 31
How to recognize and manage COVID-19-associated coagulopathy
Gerber, G. F., & Chaturvedi, S. (2021) · Hematology · doi:10.1182/hematology.2021000297 · Cited by 31
Unusual clotting dynamics of plasma supplemented with iron(III)
Jankun, J., LANDETA, P., Pretorius, E., Skrzypczak‐Jankun, E., & Lipiński, B. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1585 · Cited by 30
Self-citationIncreased serum catalytic iron may mediate tissue injury and death in patients with COVID-19
Chakurkar, V., Rajapurkar, M. M., Lele, S. S., Mukhopadhyay, B. N., Lobo, V., Injarapu, R., Sheikh, M., Dholu, B., Ghosh, A., & Jha, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-99142-x · Cited by 28
Wang, Q., Cheng, J., Shang, J., Wang, Y., Wan, J., Yan, Y., Liu, W., Zhang, H., Wang, J., Wang, X., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043790 · Cited by 27
Albumin Stabilizes Fibrin Fiber Ultrastructure in Low Serum Albumin Type 2 Diabetes
Pretorius, E., Lipiński, B., Bester, J., Vermeulen, N., & Soma, P. (2013) · Ultrastructural Pathology · doi:10.3109/01913123.2013.778929 · Cited by 26
Self-citationDrabik, D., Chodaczek, G., & Kraszewski, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010018 · Cited by 26
Role of Iron Chelation and Protease Inhibition of Natural Products on COVID-19 Infection
Carota, G., Ronsisvalle, S., Panarello, F., Tibullo, D., Nicolosi, A., & Volti, G. L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112306 · Cited by 26
Pretorius, E., Vermeulen, N., Bester, J., & Lipiński, B. (2012) · Microscopy Research and Technique · doi:10.1002/jemt.22163 · Cited by 25
Self-citationUse and Utility of Hemostatic Screening in Adults Undergoing Elective, Non-Cardiac Surgery
Weil, I. A., Seicean, S., Neuhauser, D. B., Schiltz, N. K., & Seicean, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139139 · Cited by 25
Swanepoel, A. C., Visagie, A., de Lange, Z., Emmerson, O., Nielsen, V. G., & Pretorius, E. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.08.022 · Cited by 25
Self-citationFluorescence Phenomena in Amyloid and Amyloidogenic Bionanostructures
Apter, B., Lapshina, N., Barhum, H., Fainberg, B. D., Handelman, A., Accardo, A., Diaferia, C., Ginzburg, P., Morelli, G., & Rosenman, G. I. (2020) · Crystals · doi:10.3390/cryst10080668 · Cited by 24
Therapeutic potential of induced iron depletion using iron chelators in Covid-19
Naseef, P. P., Elayadeth‐Meethal, M., Salim, K. T. M., Anjana, A., Muhas, C., Vajid, K. A., & Kuruniyan, M. S. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.11.061 · Cited by 24
Akt-Fas to Quell Aberrant T Cell Differentiation and Apoptosis in Covid-19
Leonardi, A. J., & Proenca, R. B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.600405 · Cited by 23
Systemic amyloidoses and proteomics: The state of the art
Lavatelli, F., Fonzo, A. D., Palladini, G. O., & Merlini, G. (2016) · EuPA Open Proteomics · doi:10.1016/j.euprot.2016.02.003 · Cited by 22
COVID-19: Attacks the 1-beta Chain of Hemoglobin to Disrupt Respiratory Function and Escape ImmunityPreprint
Liu, W., & hualan, L. (2022) · ChemRxiv · doi:10.26434/chemrxiv-2021-dtpv3-v11 · Cited by 22
Wang, F., Wang, X., Abskharon, R. N. N., & Ma, J. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0534-0 · Cited by 21
Haidinger, M., Werzowa, J. M., Kain, R., Antlanger, M., Hecking, M., Pfaffenberger, S., Mascherbauer, J., Gremmel, T., Gilbertson, J. A., Rowczenio, D. M., et al. (2013) · Amyloid · doi:10.3109/13506129.2013.781998 · Cited by 20
Warman, A., Warman, P. I., Sharma, A., Parikh, P., Warman, R., Viswanadhan, N., Chen, L., Mohapatra, S., Mohapatra, S. S., & Sapiro, G. (2020) · medRxiv · doi:10.1101/2020.05.16.20103408 · Cited by 20
Thagard, P. R. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511814273.026 · Cited by 19
Douillet, D., Riou, J., Penaloza, A., Moumneh, T., Soulié, C., Savary, D., Morin, F., Mahieu, R., & Roy, P. (2021) · Thrombosis Research · doi:10.1016/j.thromres.2021.10.001 · Cited by 19
Understanding COVID-19-associated coagulopathy: From PIC to SIC or DIC
Wang, Z., Gao, X., He, M., Ma, X., & Ding, R. (2021) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2021.03.002 · Cited by 18
de Villiers, S., Bester, J., Kell, D. B., & Pretorius, E. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01262 · Cited by 16
Self-citationYoon, G., Lee, M., Kim, K., Kim, J. I., Chang, H. J., Baek, I., Eom, K., & Na, S. (2015) · Physical Biology · doi:10.1088/1478-3975/12/6/066021 · Cited by 14
Shovlin, C. L., & Vizcaychipi, M. P. (2020) · QJM · doi:10.1093/qjmed/hcaa241 · Cited by 14
Vizcaychipi, M. P., Shovlin, C. L., McCarthy, A., Howard, A., Brown, A. F., Hayes, M., Singh, S., Christie, L. E., Sisson, A., Davies, R., et al. (2020) · Emergency Medicine Journal · doi:10.1136/emermed-2020-210199 · Cited by 14
Campione, E., Lanna, C., Cosio, T., Rosa, L., Conte, M. P., Iacovelli, F., Romeo, A., Falconi, M., Vecchio, C. D., Franchin, E., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.11.244996 · Cited by 14
Lessons learnt from COVID‐19 coagulopathy
Thachil, J. V. (2021) · eJHaem · doi:10.1002/jha2.228 · Cited by 13
Gurdasani, D., Akrami, A., Bradley, V. C., Costello, A. M. D. L., Greenhalgh, T., Flaxman, S. R., McKee, M., Michie, S., Pagel, C., Rasmussen, S. D., et al. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(21)00342-4 · Cited by 12
Magnusson, K., Appelqvist, H., Cieślar‐Pobuda, A., Bäck, M., Kågedal, B., Jonasson, J., Łoś, M., & Nilsson, K. P. R. (2015) · Frontiers in Chemistry · doi:10.3389/fchem.2015.00058 · Cited by 10
Swanepoel, A. C., Lindeque, B. G., Swart, P. J., Abdool, Z., & Pretorius, E. (2014) · Microscopy Research and Technique · doi:10.1002/jemt.22385 · Cited by 8
Self-citationKozieł, M., Potpara, T., & Lip, G. Y. H. (2020) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12319 · Cited by 7
Promotion of non-evidence-based therapeutics within patient-led Long COVID support groups
van der Togt, V., McFarland, S., Esperti, M., Semper, E., Citrenbaum, S., & Rossman, J. S. (2021) · Nature Medicine · doi:10.1038/s41591-021-01589-y · Cited by 3
Cited by
Yin, K., Peluso, M. J., Luo, X., Thomas, R., Shin, M.-G., Neidleman, J., Andrew, A., Young, K. C., Ma, T., Hoh, R., et al. (2024) · Nature Immunology · doi:10.1038/s41590-023-01724-6 · Cited by 394
Altmann, D. M., Whettlock, E. M., Liu, S., Arachchillage, D. J., & Boyton, R. J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00904-7 · Cited by 389
Muscle abnormalities worsen after post-exertional malaise in long COVID
Appelman, B., Charlton, B. T., Goulding, R. P., Kerkhoff, T. J., Breedveld, E. A., Noort, W., Offringa, C., Bloemers, F. W., van Weeghel, M., Schomakers, B. V., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44432-3 · Cited by 360
Komaroff, A. L., & Lipkin, W. I. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1187163 · Cited by 317
Are vaccines a potential treatment for long COVID?
Sivan, M., Greenhalgh, T., Milne, R., & Delaney, B. (2022) · BMJ · doi:10.1136/bmj.o988 · Cited by 27
Metadata
- Authors
- Kell, D. B., Laubscher, G. J., & Pretorius, E.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2022-02-23
- Volume
- 479
- Issue
- 4
- Pages
- 537-559
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W4213445300
- Cited by
- 271
- References
- 239
- FWCI
- 32.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.